Why the study?
It remains unknown whether tirofiban improves clinical outcomes in patients with large vessel occlusion stroke undergoing endovascular treatment within 24 hours of symptom onset.
Does intravenous tirofiban improve disability level in large vessel occlusion stroke patients undergoing endovascular treatment?
Population
Up to 930 large vessel occlusion stroke patients undergoing endovascular treatment within 24 h of symptom onset
Comparison
Intravenous tirofiban vs placebo
Design
Investigator-initiated, randomized, placebo-controlled, double-blind, multicenter trial
Follow-up
90 days
Authors
Loading...
Tirofiban adjunct in LVO stroke EVT remains unproven; RESCUE BT RCT will deliver first dedicated efficacy-safety data.
Does intravenous tirofiban improve disability level in large vessel occlusion stroke patients undergoing endovascular treatment?
This protocol describes the RESCUE BT trial, which will evaluate the efficacy and safety of intravenous tirofiban in patients with large vessel occlusion stroke undergoing endovascular treatment.
Qiu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: